Drug delivery in biotechnology: Present and future

225Citations
Citations of this article
289Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Drug delivery is becoming a whole interdisciplinary and independent field of research and is gaining the attention of pharmaceutical makers, medical doctors and industry. A targeted and safe drug delivery could improve the performance of some classical medicines already on the market and, moreover, will have implications for the development and success of new therapeutic strategies, such as peptide and protein delivery, glycoprotein administration, gene therapy and RNA interference. Many innovative technologies for effective drug delivery have been developed, including implants, nanotechnology, cell and peptide encapsulation, microfabrication, chemical modification and others. On the long way from the clinic to market, however, several issues will have to be addressed, including suitable scientific development, specific financial support as a result of altered scientific policy, government regulations and market forces.

Cite

CITATION STYLE

APA

Orive, G., Hernández, R. M., Gascón, A. R., Domínguez-Gil, A., & Pedraz, J. L. (2003). Drug delivery in biotechnology: Present and future. Current Opinion in Biotechnology. Elsevier Ltd. https://doi.org/10.1016/j.copbio.2003.10.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free